论文部分内容阅读
选取我院2015年1月~2016年1月收治的50例胃溃疡患者,按照患者住院的先后顺序,分成观察组和对照组,各25例。观察组通过雷贝拉唑、克拉霉素、阿莫西林联合治疗,对照组给予奥美拉唑、克拉霉素、阿莫西林联合治疗,对比两组临床疗效、不良反应情况。结果观察组和对照组的治疗总有效率、不良反应发生率分别为:96%、8%;72%、36%;组间比较,差异显著,P<0.05。结论胃溃疡通过雷贝拉唑、克拉霉素、阿莫西林联合治疗,临床效果较佳,且能有效的控制不良反应发生率,值得临床深入推广。
Fifty patients with gastric ulcer admitted from January 2015 to January 2016 in our hospital were divided into observation group and control group according to the order of hospitalization and 25 patients in each group. The observation group was treated with rabeprazole, clarithromycin and amoxicillin. The control group was treated with omeprazole, clarithromycin and amoxicillin. The clinical efficacy and adverse reactions of the two groups were compared. Results The total effective rate of treatment and adverse reactions in observation group and control group were 96%, 8%, 72% and 36% respectively. There was significant difference between two groups (P <0.05). Conclusions Gastric ulcer through rabeprazole, clarithromycin, amoxicillin combined treatment, the clinical effect is better, and can effectively control the incidence of adverse reactions, it is worth further clinical promotion.